ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,524Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 444

$371K Total Retail Price of All Prescriptions

Rank: 113 out of 444

921 Patients Receiving at Least One Drug in Part D
93% Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nevada
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

2% of this provider’s 921 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 921 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 402 354 164 1 1
AMLODIPINE BESYLATE 392 381 135 2 6
LEVOTHYROXINE SODIUM 361 323 135 3 2
SIMVASTATIN 339 327 141 4 3
OMEPRAZOLE 331 305 141 5 5
PRAVASTATIN SODIUM 322 308 131 6 16
HYDROCHLOROTHIAZIDE 207 178 82 7 10
LOSARTAN POTASSIUM 203 198* 88 8 9
METFORMIN HCL 167 154 71 9 7
WARFARIN SODIUM 154 149* 49 10 22
FUROSEMIDE 150 145* 65 11 12
ALENDRONATE SODIUM 150 145* 59 11 18
METOPROLOL SUCCINATE 136 131* 48 13 20
ALLOPURINOL 134 134 47 14 30
GABAPENTIN 130 116 47 15 11
HYDROCODONE-ACETAMINOPHEN 129 109 84 S3 16 4
CLOPIDOGREL 122 107 39 17 24
ATORVASTATIN CALCIUM 122 117* 41 17 8
VENTOLIN HFA 122 104 39 17 34
ATENOLOL 118 113* 48 20 17
BD ULTRA-FINE PEN NEEDLE 109 104* 42 21 87
CARVEDILOL 103 98* 44 22 26
METOPROLOL TARTRATE 102 97* 36 23 14
FLUTICASONE PROPIONATE 100 84 36 24 27
LOSARTAN-HYDROCHLOROTHIAZIDE 93 93 32 25 35
TERAZOSIN HCL 92 92 42 26 46
FLUOXETINE HCL 90 75 31 27 39
SPIRIVA 89 78 27 28 41
GLIPIZIDE 89 84* 32 28 33
LOVASTATIN 82 77* 34 30 15
ZOLPIDEM TARTRATE 81 76* 49 31 19
GLIPIZIDE ER 74 74 33 32 61
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 73 30 33 23
CLONIDINE HCL 73 73 23 33 67
TRAZODONE HCL 68 55 26 35 32
LEVEMIR FLEXPEN 68 68 25 35 135
GEMFIBROZIL 65 60* 31 37 71
METFORMIN HCL ER 64 59* 22 38 52
DONEPEZIL HCL 60 60 19 39 38
IBUPROFEN 58 53* 25 40 55
ALPRAZOLAM 58 47 32 B 40 13
RANITIDINE HCL 58 53* 17 40 36
KLOR-CON 10 55 55 23 43 154
CITALOPRAM HBR 54 49* 26 44 25
FENOFIBRATE* 51 38 21 45 50
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.